Integer Holdings Corporation (ITGR) Financials

ITGR Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 3.4 billion 1.7 billion
Dec. 31, 2025 3.4 billion 1.7 billion
Sept. 30, 2025 3.4 billion 1.7 billion
June 30, 2025 3.4 billion 1.7 billion

ITGR Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 737000 6.7 million
Dec. 31, 2025 27.9 million 5.8 million
Sept. 30, 2025 46.3 million 4.9 million
June 30, 2025 69.1 million 5.7 million

ITGR Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 16.5 million
Dec. 31, 2025 48.6 million
Sept. 30, 2025 39.7 million
June 30, 2025 37.0 million

ITGR Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 8.1 million 1.3 billion 129.9 million
Dec. 31, 2025 17.2 million 1.3 billion 110.5 million
Sept. 30, 2025 58.9 million 1.2 billion 108.2 million
June 30, 2025 23.1 million 1.2 billion 109.7 million

ITGR Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 34.4 million
Dec. 31, 2025 35.1 million
Sept. 30, 2025 35.6 million
June 30, 2025 35.7 million

ITGR Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 24.0 million 16.2 million 55.4 million -
Dec. 31, 2025 27.5 million 10.1 million 43.7 million -
Sept. 30, 2025 19.3 million 10.9 million 37.6 million -
June 30, 2025 25.2 million 14.2 million 40.2 million -

ITGR Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 439.6 million 330.0 million
Dec. 31, 2025 470.9 million 364.8 million
Sept. 30, 2025 466.6 million 358.3 million
June 30, 2025 472.8 million 365.5 million

ITGR Revenue by Segment

Graph available only for paid members. Upgrade to see it.

ITGR

Price: $90.85

52 week price:
62.00
123.78

Earnings Per Share: 4.03 USD

P/E Ratio: 21.30

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 90525

Ebitda: 63.8 million

Market Capitalization: 3.1 billion

Links: